-Newsclick.in The recent agreements between Medicine Patent Pool and Big Pharma are being projected as benevolent gestures from pharma companies in sharing their patented technologies with other countries. The fact is it is working towards cementing its monopoly power further. The development of anti-viral oral pills to combat COVID-19 will, hopefully, make the fight against the pandemic more promising. While Merck has developed the anti-viral pill Molnupiravir, Pfizer has come up with...
More »SEARCH RESULT
The AIDS fight offers a COVID vaccine patent pathway -Murphy Halliburton
-The Hindu There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners voluntarily licensing their products to other companies, especially Indian producers who are experienced at...
More »Low-end wart in FDI in research -GS Mudur
-The Telegraph New Delhi: Foreign corporations have created over 247,000 jobs through research and development (R&D) investments in India over the past decade, but most of the activities appear relatively unimportant with little long-term gains , researchers have said. The study, described as the first comprehensive assessment of foreign direct investment (FDI) in R&D, has challenged suggestions by Indian science policy makers and foreign corporations a decade ago that turning India into...
More »Glivec lesson for pharma: Patented drugs must be priced smartly-Kiran Mazumdar Shaw
-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...
More »The dark underbelly of India’s clinical trials business-Malia Politzer and Vidya Krishnan
-Live Mint Incidents at Bhopal and Indore highlight irregularities and ethical violations in some trials In 2004, doctors at the Bhopal Memorial Hospital and Research Centre (BMHRC), established exclusively for treating the victims of the 1984 gas leak, recruited unsuspecting survivors for clinical trials without their knowledge or consent; 14 participants died during the course of the trials. Together with the episode in Indore’s Maharaja Yashwantrao Hospital (that Mint reported on 10...
More »